Sobatum
tradename; active fraction of Solanum trilobatum; reduces side-effects of radiation-induced toxicity
Networked: 5
relevant articles (0 outcomes,
0 trials/studies)
Bio-Agent Context: Research Results
Related Diseases
| 1. | Lymphoma (Lymphomas)
|
| 2. | Body Weight (Weight, Body)
01/30/1998
- " The results indicated that there was significantly less body weight gain and food intake in the radiation alone-treated group compared to the Sobatum-treated group. " 01/30/1998
- " Group I, the control group, received radiation alone, while groups II and III received Sobatum (100 and 200 mg/kg body weight, respectively) with radiation. " 09/26/1996
- " In the second set of experiment (72 h after the second administration) consisting of 5 groups, the first, as control, received dimethyl sulfoxide, the second, third and fourth groups received different concentrations of the Sobatum (100, 200, 400 mg/kg body weight), and the fifth group as positive control received cyclophosphamide (100 mg/kg body weight). " 09/26/1996
- " The first group (as control) received only dimethyl sulfoxide, the second, third and fourth groups received different doses of the Sobatum (100, 200, 400 mg/kg body weight), and the fifth group (as positive control) received cyclophosphamide (100 mg/kg body weight) by i.p. "
|
| 3. | Ascites
|
| 4. | Carcinogenesis
|
|
Related Drugs and Biologics